2. Cell Cycle/DNA Damage Autophagy Apoptosis
  3. Nucleoside Antimetabolite/Analog DNA/RNA Synthesis Autophagy Apoptosis
  4. Gemcitabine

Gemcitabine  (Synonyms: LY 188011)

Cat. No.: HY-17026 Purity: 99.72%
COA Handling Instructions

Gemcitabine (LY 188011) est un pyrimidine nucléoside analogue antimétabolite et un agent antinéoplasique. Gemcitabine inhibe la synthèse de l'ADN et la réparation, entraînant l'autophagie et l'apoptose. Gemcitabine inhibe la croissance des cellules de BxPC-3, de Mia Paca-2, de PANC-1, de PL-45 et de AsPC-1 avec des IC50 de 37,6 nM, 42,9 nM, 92,7 nM, 89,3 nM et 131,4 nM, respectivement.

Gemcitabin (LY 188011) ist ein pyrimidine nucleoside-Antimetabolit und ein antineoplastisches Mittel. Gemcitabin hemmt die DNA synthesis und -Reparatur, was zu autophagy und apoptosis führt. Gemcitabin hemmt das Wachstum von BxPC-3-, Mia Paca-2-, PANC-1-, PL-45- und AsPC-1-Zellen mit IC50s von 37,6 nM, 42,9 nM, 92,7 nM, 89,3 nM bzw. 131,4 nM.

Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis.

For research use only. We do not sell to patients.

Gemcitabine Chemical Structure

Gemcitabine Chemical Structure

CAS No. : 95058-81-4

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solution
10 mM * 1 mL in DMSO USD 66 In-stock
Solid + Solvent
10 mM * 1 mL
ready for reconstitution
 USD 66 In-stock
Solid
100 mg USD 60 In-stock
200 mg USD 72 In-stock
500 mg USD 102 In-stock
1 g USD 120 In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 100 publication(s) in Google Scholar

Other Forms of Gemcitabine:

Gemcitabine Related Antibodies

Top Publications Citing Use of Products

97 Publications Citing Use of MCE Gemcitabine

Proliferation Assay
WB

    Gemcitabine purchased from MCE. Usage Cited in: Naunyn Schmiedebergs Arch Pharmacol. 2019 May;392(5):615-622.  [Abstract]

    The expression level of p-JAK2, p-STAT3, Bcl-XL, and Mcl-1 in PANC-1 cells is detected by western blot analysis and is all down-regulated in the treatment groups.

    Gemcitabine purchased from MCE. Usage Cited in: Chem Biol Interact. 2018 Jun 25;290:44-51.  [Abstract]

    U2OS and MG-63 cells are treated with Gemcitabine, Licoricidin, or Gemcitabine+Licoricidin for 24 h, followed by the determination of active caspse-3 protein level using western blot. Cells without treatment are used as Control.

    Gemcitabine purchased from MCE. Usage Cited in: J Biol Chem. 2017 Jun 2;292(22):9136-9149.  [Abstract]

    The plate clone formation of SW480 and SW620 cells with Gemcitabine (8 nM in SW480 and 16 nM in SW620) and/or PX-12 (4 μM in SW480 and 8 μM in SW620).

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].

    IC50 & Target

    DNA synthesis[1]
    In Vitro

    Gemcitabine (purchased from MedChem Express, 0.003-1 μM; 3 days) kills both mouse and human senescent cells effectively and potently[4].
    Gemcitabine inhibits the growth of BxPC-3, Mia Paca-2, PANC-1, PL-45 and AsPC-1 cells with IC50s of 37.6, 42.9, 92.7, 89.3 and 131.4 nM, respectively[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Gemcitabine Related Antibodies

    Cell Viability Assay[4]

    Cell Line: Non-senescent and replication-induced senescent new born dermal fibroblasts (NBFs)
    Concentration: 0.003, 0.01, 0.03, 0.1, 0.3, 1 μM
    Incubation Time: 3 days
    Result: Killed replication-induced senescent NBFs for 3 days with 11.0% cell viability.
    In Vivo

    Gemcitabine can be administered via endotracheal spray in rats without marked toxicity with a maximum tolerated dose of 4 mg/kg once a week for 9 weeks. The toxicity of Gemcitabine is lower via lung than oral administration at dosages of 2, 4, and 6 mg/kg[2].
    Treatment of the LSL-KrasG12D/+; LSL-Trp53R172H; Pdx-1-Cre mice with either Gemcitabine (50 mg/kg, i.p.) or the combination DMAPT/Gemcitabine significantly increases the median survival time by more than 30 days compared to the placebo group (254.5 or 255 days vs. 217.5 days, respectively)[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.
    Clinical Trial
    Molecular Weight

    263.20

    Appearance

    Solid

    Formula

    C9H11F2N3O4
    CAS No.
    SMILES

    NC(C=CN1[C@H]2C(F)(F)[C@H](O)[C@@H](CO)O2)=NC1=O
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 250 mg/mL (949.85 mM; Need ultrasonic)

    Ethanol : 12.5 mg/mL (47.49 mM; Need ultrasonic)

    H2O : 6.25 mg/mL (23.75 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.7994 mL 18.9970 mL 37.9939 mL
    5 mM 0.7599 mL 3.7994 mL 7.5988 mL
    10 mM 0.3799 mL 1.8997 mL 3.7994 mL
    *Please refer to the solubility information to select the appropriate solvent.
    In Vivo:
    • 1.

      Add each solvent one by one:  0.5%HPMC  1%Tween80

      Solubility: 20 mg/mL (75.99 mM); Clear solution; Need ultrasonic

    • 2.

      Add each solvent one by one:  5% DMSO    40% PEG300    5% Tween-80    50% saline

      Solubility: ≥ 2.62 mg/mL (9.95 mM); Clear solution

    • 3.

      Add each solvent one by one:  5% DMSO    95% (20% SBE-β-CD in saline)

      Solubility: ≥ 2.62 mg/mL (9.95 mM); Clear solution

    • 4.

      Add each solvent one by one:  10% DMSO    90% corn oil

      Solubility: ≥ 2.58 mg/mL (9.80 mM); Clear solution

    • 5.

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

      Solubility: ≥ 2.08 mg/mL (7.90 mM); Clear solution

    • 6.

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

      Solubility: ≥ 2.08 mg/mL (7.90 mM); Clear solution

    • 7.

      Add each solvent one by one:  10% DMSO    90% corn oil

      Solubility: ≥ 2.08 mg/mL (7.90 mM); Clear solution

    • 8.

      Add each solvent one by one:  1% DMSO    99% saline

      Solubility: ≥ 0.52 mg/mL (1.98 mM); Clear solution

    *All of the co-solvents are available by MCE.
    Purity & Documentation

    Purity: 99.92%

    COA (254 KB) HNMR (173 KB) LCMS (106 KB) Elemental Analysis Report (112 KB)

    Handling Instructions (2659 KB)
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Gemcitabine Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Keywords:

    Gemcitabine95058-81-4LY 188011LY188011LY-188011Nucleoside Antimetabolite/AnalogDNA/RNA SynthesisAutophagyApoptosisInhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Salutation

    Applicant Name *

    		 

    Email Address *

    Phone Number *

    		 

    Organization Name *

    Department *

    		 

    Requested quantity *

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Gemcitabine
    Cat. No.:
    HY-17026
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.